Cargando…
The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
This study aimed to evaluate and compare the effects of various endocrine therapies on lipid profiles in young patients with breast cancer. A retrospective, single-center study was performed to investigate the effects of tamoxifen (TAM), tamoxifen plus ovarian function suppression (TAM+OFS), and aro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671131/ https://www.ncbi.nlm.nih.gov/pubmed/34926260 http://dx.doi.org/10.3389/fonc.2021.759595 |
_version_ | 1784615105575518208 |
---|---|
author | Kang, Yi-Kun Wang, Xue Hu, Nan-Lin Yue, Jian Si, Yi-Ran Ju, Jie Gao, Song-Lin Yuan, Peng |
author_facet | Kang, Yi-Kun Wang, Xue Hu, Nan-Lin Yue, Jian Si, Yi-Ran Ju, Jie Gao, Song-Lin Yuan, Peng |
author_sort | Kang, Yi-Kun |
collection | PubMed |
description | This study aimed to evaluate and compare the effects of various endocrine therapies on lipid profiles in young patients with breast cancer. A retrospective, single-center study was performed to investigate the effects of tamoxifen (TAM), tamoxifen plus ovarian function suppression (TAM+OFS), and aromatase inhibitors plus ovarian function suppression (AI+OFS) on lipid profiles during the 60 months of endocrine therapy in hormone receptor-positive patients aged <40 with early breast cancer. The primary endpoint was the cumulative incidence of lipid events, and the secondary endpoints were the changes in lipid profiles. A total of 230 young patients were included with the mean age of 35.7 years old. The patients in TAM group had significantly lower incidence of 5-year lipid events than those in TAM+OFS group (7.4% versus 21.3%; P=0.016) and AI+OFS group (7.4% versus 21.6%; P=0.009). The incidence of fatty liver was significantly higher in TAM+OFS group than TAM group (52.5%versus 30.9%; P=0.043). Lipid events were associated with younger age (odds ratio (OR)=0.865, 95% confidence interval (CI): 0.780-0960; P=0.006), higher baseline LDL-C (OR=14.959, 95% CI: 4.379-51.105; P<0.001), and use of OFS (OR=3.557, 95% CI: 1.151-10.989; P=0.027). Therefore, application of OFS, with younger age and higher baseline LDL-C, may increase the incidence of lipid events in premenopausal breast cancer. More care should be taken for lipid profiles during the endocrine therapy for young breast cancer patients. |
format | Online Article Text |
id | pubmed-8671131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86711312021-12-16 The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer Kang, Yi-Kun Wang, Xue Hu, Nan-Lin Yue, Jian Si, Yi-Ran Ju, Jie Gao, Song-Lin Yuan, Peng Front Oncol Oncology This study aimed to evaluate and compare the effects of various endocrine therapies on lipid profiles in young patients with breast cancer. A retrospective, single-center study was performed to investigate the effects of tamoxifen (TAM), tamoxifen plus ovarian function suppression (TAM+OFS), and aromatase inhibitors plus ovarian function suppression (AI+OFS) on lipid profiles during the 60 months of endocrine therapy in hormone receptor-positive patients aged <40 with early breast cancer. The primary endpoint was the cumulative incidence of lipid events, and the secondary endpoints were the changes in lipid profiles. A total of 230 young patients were included with the mean age of 35.7 years old. The patients in TAM group had significantly lower incidence of 5-year lipid events than those in TAM+OFS group (7.4% versus 21.3%; P=0.016) and AI+OFS group (7.4% versus 21.6%; P=0.009). The incidence of fatty liver was significantly higher in TAM+OFS group than TAM group (52.5%versus 30.9%; P=0.043). Lipid events were associated with younger age (odds ratio (OR)=0.865, 95% confidence interval (CI): 0.780-0960; P=0.006), higher baseline LDL-C (OR=14.959, 95% CI: 4.379-51.105; P<0.001), and use of OFS (OR=3.557, 95% CI: 1.151-10.989; P=0.027). Therefore, application of OFS, with younger age and higher baseline LDL-C, may increase the incidence of lipid events in premenopausal breast cancer. More care should be taken for lipid profiles during the endocrine therapy for young breast cancer patients. Frontiers Media S.A. 2021-12-01 /pmc/articles/PMC8671131/ /pubmed/34926260 http://dx.doi.org/10.3389/fonc.2021.759595 Text en Copyright © 2021 Kang, Wang, Hu, Yue, Si, Ju, Gao and Yuan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kang, Yi-Kun Wang, Xue Hu, Nan-Lin Yue, Jian Si, Yi-Ran Ju, Jie Gao, Song-Lin Yuan, Peng The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer |
title | The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer |
title_full | The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer |
title_fullStr | The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer |
title_full_unstemmed | The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer |
title_short | The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer |
title_sort | effects of endocrine therapies on lipid profiles in chinese young women with early breast cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671131/ https://www.ncbi.nlm.nih.gov/pubmed/34926260 http://dx.doi.org/10.3389/fonc.2021.759595 |
work_keys_str_mv | AT kangyikun theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT wangxue theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT hunanlin theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT yuejian theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT siyiran theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT jujie theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT gaosonglin theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT yuanpeng theeffectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT kangyikun effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT wangxue effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT hunanlin effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT yuejian effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT siyiran effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT jujie effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT gaosonglin effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer AT yuanpeng effectsofendocrinetherapiesonlipidprofilesinchineseyoungwomenwithearlybreastcancer |